MedCity News May 11, 2021
Mayo Clinic is ramping up activity in the remote patient monitoring arena. Its latest move is a collaboration with biomedical technology company NXgenPort, which will focus on an implantable catheter that can remotely monitor cancer patients for complications as they undergo treatment.
Just a month after Mayo Clinic announced the launch of Lucem Health — a joint venture that collects and normalizes data from remote devices — the health system is making another move in the remote patient monitoring arena.
On Tuesday, the Rochester, Minnesota-based health system said it is collaborating with a biomedical technology company to support the development of a cancer-focused remote patient monitoring tool.
The company is NXgenPort, headquartered in Minneapolis and Ventura, California. The company’s medical...